喉鳞状细胞癌诊断至治疗间隔延长的相关因素
基于美国国家癌症数据库2004至2017年51,747例接受初治放疗或手术的喉鳞状细胞癌患者的回顾性队列研究,评估诊断至治疗间隔延长的相关因素及其对生存的影响,发现少数族裔、高龄、女性、距治疗机构≥30英里、无保险、学术癌症中心治疗和初治放疗与间隔延长相关,而社区癌症中心治疗虽间隔较短但与更高死亡率独立相关。
要点
- 少数族裔、高龄、女性、距治疗机构≥30英里、无保险、学术癌症中心治疗和初治放疗与诊断至治疗间隔延长相关。
- 社区癌症中心治疗虽诊断至治疗间隔较短,但与更高死亡率独立相关(HR 1.2,P < .0001)。
- 在高体量学术机构治疗虽与诊断至治疗间隔延长相关,但与显著改善的生存相关。
核心结论
- 在高体量学术机构治疗虽与诊断至治疗间隔延长相关,但与显著改善的生存相关。
- 作者认为,改进转诊路径或外展服务可能有助于改善喉癌生存,尤其是在高危人群中。
研究设计与样本
- 回顾性队列研究,数据来自美国国家癌症数据库。
- 纳入2004至2017年接受初治放疗或手术的喉鳞状细胞癌患者,排除后共51,747例,其中18,499例接受初治手术,33,248例接受初治放疗。
主要发现
- 少数族裔、高龄、女性、距治疗机构≥30英里、无保险、学术癌症中心治疗和初治放疗与诊断至治疗间隔延长相关。
- 社区癌症中心治疗与更高死亡率独立相关(风险比1.2;P < .0001)。
关键数值与推荐
- 诊断至治疗间隔延长定义为>30天。
- 社区癌症中心治疗与更高死亡率独立相关(风险比1.2;P < .0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Evaluate factors associated with treatment delays and their effect on survival in laryngeal squamous cell carcinoma. STUDY DESIGN: Retrospective cohort study. SETTING: National Cancer Database. METHODS: Patients receiving primary radiation or surgery for laryngeal squamous cell carcinoma were included from 2004 to 2017. The primary outcomes were the diagnosis-to-treatment interval (DTI) and 5-year survival. Variables of prolonged DTI (>30 days) were assessed via logistic regression models. Survival was then assessed through Cox proportional hazards models. Candidate variables for both outcomes included age, sex, race, ethnicity, distance to treatment facility, insurance coverage, treatment facility type, TNM T stage, nodal status, and DTI (in models estimating survival). RESULTS: An overall 136,203 patients with laryngeal cancer were identified, from which 51,747 remained after exclusions were applied: 18,499 received primary surgery and 33,248 received primary radiation. Being a member of a racial or ethnic minority, advanced age, female sex, ≥30 miles from treatment facility, lack of insurance, treatment at an academic cancer center, and primary radiation were associated with a prolonged DTI. However, in spite of a faster DTI, treatment at a community cancer center was independently associated with higher mortality (hazard ratio, 1.2; P < .0001). CONCLUSIONS: Despite being associated with prolonged DTI, receiving treatment at a high-volume academic facility was associated with significantly improved survival. Our results indicate that improved referral pathways or outreach may help improve survival in laryngeal cancer, especially in high-risk populations.
引用
- Shaikh N, Morrow V, Stokes C, et al. Factors Associated With a Prolonged Diagnosis-to-Treatment Interval in Laryngeal Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2022. PMID: 35380886. doi:10.1177/01945998221090115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。